Instructor in the Division of Neurotherapeutics at Harvard University and a neuroimmunologist with expertise in persistent central nervous system consequences. Mike uses functional and structural imaging techniques to identify abnormal patterns in brain inflammation and metabolism in patients with infection-associated chronic disease. He facilitates collaboration among PolyBio research teams and serves on the Board of Directors. He received a master’s degree in behavioral neuroscience at the University of Colorado and a PhD in experimental clinical psychology at Tufts University.

Microbiologist with expertise on the molecular mechanisms by which persistent pathogens modulate human gene expression, metabolism and immunity. Serves as PolyBio’s President, Research Director, and on the Board of Directors. Amy is an expert in conceptualizing and coordinating large-scale collaborative research projects. She has written multiple review articles that delineate core biological drivers of the LongCovid and ME/CFS disease processes. She holds a Bachelor of Science in biology from Georgetown University and a PhD in microbiology from Murdoch University in Australia.

Infectious disease physician with expertise in pediatric tickborne disease and HIV/AIDS. Charlotte worked at the Dean Center for Tickborne Illness and Pediatric Infectious Disease at Massachusetts General Hospital. She is passionate about translating research on Borrelia burgdorferi and related tick-borne pathogens into cutting-edge clinical care. Charlotte received her medical degree from Harvard Medical School and did residency training in pediatric infectious diseases at Boston Children’s Hospital. She also serves on PolyBio’s Board of Directors.

Clinician-scientist determined to map inflammatory signatures specific to the microbiome in a creative fashion. Also an oral surgeon, Professor of Genomic Medicine, and member of the J. Craig Venter Institute infectious disease department. Life prior to disease is his mantra! Marcelo holds a DDS from College of Dentistry, Campos, Rio de Janeiro, a PhD in Craniofacial Molecular Biology from University of Southern California, and a DMedSc in Oral Medicine and Infectious Diseases from Harvard University.

Instructor in the Neurology Department of Massachusetts General Hospital & Harvard Medical School. Innovator of experimental models for the study of amyloid biology and infection in neurodegenerative disease. His current research focuses on characterizing amyloid’s activity as an antimicrobial peptide that forms in response to viral and bacterial pathogens. William holds a PhD in Neuroscience from Northwestern University and completed postdoctoral work on genetics & Alzheimer’s disease biology at Harvard University.

Scientist at the Max-Planck-Institute for Biology of Ageing working to understand how cellular organelles sense and respond to intracellular pathogens. Expert in mitochondrial dynamics, parasite biology, and immunometabolism. Lena holds a PhD in microbiology & immunology from Stanford University and completed postdoctoral research on the biology of infection at the University of Padua, Italy.

CRISPR-Cas system discovery specialist at Mammoth Biosciences with a passion for developing & using technologies to identify novel genes from big data. Co-founder & Head of Bioinformatics at Ancilia Therapeutics focused on bacteriophage genomics and microbiome. Also an affiliate at the Lawrence Berkeley National Lab, Joint Genome Institute. David holds a Ph.D. in synthetic and molecular biology and biochemistry techniques from the CNB-CSIC in Madrid, Spain, and completed a postdoctoral position at UC Berkeley on metagenomics.

2x Olympic Gold Medalist and Captain of the USA Women’s Water Polo team. She is a dedicated leader not only to her team, but also to the sport of water polo and the growth of women in sport. This passion for growth is complimented by her entrepreneurial route with her company, 6-8 Sports, which she co-founded with fellow Olympian, Tony Azevedo. At 6-8 Sports, she focuses on business development & strategy and raising funds for the company to fulfill its mission. Maggie holds a Bachelor in Science in Science, Technology, and Society as well as a Master in Science in Management & Engineering from Stanford University.

Over 15 years of experience in the private equity and investment banking industries. He is currently a Partner at Newlight Partners, where he focuses on investments in power and infrastructure. Prior to joining Newlight he worked as Managing Director to its predecessor, the Strategic Investments Group of Soros Fund Management, as an Investment Banking Analyst for Bear Stearns, and as an Analyst for the Royal Bank of Scotland. Mark holds a Bachelor in Science and Foreign Service in International Economics from Georgetown University.

Expert in organizational strategy and design. Katie currently works at the intersection of strategy and job quality at Amazon. Previously, she was a director of strategy at Starbucks and a consultant at McKinsey & Company. Katie is also a nonresident fellow at the Brookings Institution, where she has recently focused on the economic impact of LongCovid. She has served on the leadership teams at two nonprofits. Katie has an MBA from MIT Sloan, a Master’s Degree from the London School of Economics, and a BA from the University of Oxford.